Methimazole-Induced Bullous Systemic Lupus Erythematosus: A Case Report
Journal of Korean Medical Science
;
: 818-821, 2012.
Artículo
en Inglés
| WPRIM
| ID: wpr-210921
ABSTRACT
Bullous systemic lupus erythematosus (SLE) is a kind of LE-non-specific bullous skin disease that is rarely induced by a medication. We describe the first case of bullous SLE to develop after administration of methimazole. A 31-yr-old woman presented with generalized erythematous patches, multiple bullae, arthralgia, fever, conjunctivitis, and hemolytic anemia. Biopsy of her bulla showed linear deposition of lgG, lgA, C3, fibrinogen, and C1q at dermo-epidermal junction. She was diagnosed as bullous SLE and treated with prednisolone, dapsone, hydroxychloroquine, and methotrexate. Our experience suggests that SLE should be considered as a differential diagnosis when bullous skin lesions develop in patients being treated for hyperthyroidism.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Piel
/
Antitiroideos
/
Nefritis Lúpica
/
Prednisolona
/
Enfermedad de Graves
/
Vesícula
/
Antirreumáticos
/
Quimioterapia Combinada
/
Hidroxicloroquina
/
Inmunosupresores
Límite:
Adulto
/
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Journal of Korean Medical Science
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS